Katja Suter

ORCID: 0000-0001-9439-9312
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences Research and Education
  • Pharmaceutical studies and practices
  • Epilepsy research and treatment
  • Statistical Methods in Clinical Trials
  • Meta-analysis and systematic reviews
  • Innovations in Medical Education
  • Antibiotics Pharmacokinetics and Efficacy
  • Nursing Diagnosis and Documentation
  • Health Policy Implementation Science
  • Health and Medical Research Impacts
  • Drug Transport and Resistance Mechanisms
  • Education Methods and Technologies
  • Sinusitis and nasal conditions
  • Genomics, phytochemicals, and oxidative stress
  • Antibiotic Use and Resistance
  • Bipolar Disorder and Treatment
  • Urinary Tract Infections Management
  • Retinal and Macular Surgery
  • Pharmacy and Medical Practices
  • Cancer therapeutics and mechanisms
  • Pharmacological Effects of Natural Compounds
  • Neuroscience and Neuropharmacology Research
  • Medication Adherence and Compliance
  • Patient Satisfaction in Healthcare

University Hospital of Basel
2008-2025

University of Basel
2007-2025

University Hospital of Zurich
2012

Amsterdam University Medical Centers
2012

Universitäre Psychiatrische Dienste Bern
2012

Institute of Molecular and Clinical Ophthalmology Basel
2011

Roche (Switzerland)
1987-1989

Fleroxacin (Ro 23-6240; AM-833) is a new trifluorinated quinolone exhibiting high activity against broad spectrum of gram-negative and gram-positive bacteria. Healthy male volunteers received, according to randomized scheme, oral doses 200, 400, or 800 mg fleroxacin in tablet form, an intravenous infusion 100 mg, 400 orally together with 1,000 probenecid. characterized pharmacokinetically by long elimination half-life (9 10 h) concentrations plasma (e.g., maximum concentration 2.3...

10.1128/aac.31.12.1909 article EN Antimicrobial Agents and Chemotherapy 1987-12-01

Introduction: Evidence-based medicine (EBM) improves the quality of health care. Courses on how to teach EBM in practice are available, but knowledge does not automatically imply its application teaching. We aimed identify and compare barriers facilitators for teaching clinical various European countries.Methods: A questionnaire was constructed listing potential practice. Answers were reported a 7-point Likert scale ranging from at all being barrier an insurmountable barrier.Results: The...

10.3109/0142159x.2011.542520 article EN Medical Teacher 2011-02-23

To investigate the pharmacokinetics and pharmacodynamics of nasal formulations containing midazolam (5-30 mg ml(-1)) complexed with cyclodextrin.An open-label sequential trial was conducted in eight healthy subjects receiving single doses 1 3 intranasally intravenously. Pharmacokinetic parameters were obtained by non-compartmental two-compartmental models. Pharmacodynamic effects assessed using VAS a reaction time test.Mean bioavailability after administration ranged from 76 +/- 12% to 92...

10.1111/j.1365-2125.2010.03611.x article EN British Journal of Clinical Pharmacology 2010-01-12

10.1111/jep.70114 article EN cc-by Journal of Evaluation in Clinical Practice 2025-05-19

The pharmacokinetics and pharmacodynamics of a highly concentrated cyclodextrin-based intranasal (i.n.) midazolam formulation containing the absorption-enhancer chitosan were studied in 12 healthy volunteers compared with intravenous (i.v.) midazolam. pharmacodynamic (PD) effects assessed using quantitative electroencephalography (EEG). Maximal plasma concentrations 63 110 ng/ml reached at 8.4 7.6 min after 3 6 mg i.n. midazolam, respectively. After 5 i.v. times to onset significant EEG β2...

10.1038/clpt.2011.316 article EN Clinical Pharmacology & Therapeutics 2012-03-28

Alleles of the human leukocyte antigen (HLA) system have been associated with occurrence idiosyncratic adverse drug reactions (ADRs). Accordingly, it is assumed that pre-emptive testing for presence certain HLA alleles (HLA-typing) could prevent these ADRs in carriers. In order to perceive current evidence HLA-associated ADRs, we conducted a scoping review according Preferred Reporting Items Systematic Reviews and Meta-Analyses (PRISMA). The literature search on PubMed Embase was carried out...

10.1111/cts.13062 article EN cc-by-nc-nd Clinical and Translational Science 2021-06-09

Implementation of pharmacogenetics (PGx) and individualization drug therapy is supposed to obviate adverse reactions or failure. Health care professionals (HCPs) use labels (DLs) as reliable information about drugs. We analyzed the Swiss DLs give an overview on currently available PGx instructions. screened 4306 applying natural language processing focusing metabolism (pharmacokinetics) we assigned levels following classification system PharmGKB. From 5979 hits, 2564 were classified...

10.1038/s41397-020-00195-4 article EN cc-by The Pharmacogenomics Journal 2020-10-17

Importance Improving methodological quality is a priority in the health research community. Finding appropriate methods guidance can be challenging due to heterogeneous terminology, poor indexing medical databases, and variation formats. The Library of Guidance for Health Scientists (LIGHTS) new searchable database articles. Observations Journal articles that aim provide performing (including planning, design, conduct, analysis, interpretation), reporting, assessing health-related involving...

10.1001/jamanetworkopen.2022.53198 article EN cc-by-nc-nd JAMA Network Open 2023-02-14

Abstract Background Over the past decade, evidence‐based medicine (EBM) has gained recognition as a means to improve quality of health care provision. However, little is known about learning opportunities acquire EBM‐associated skills. The EUebm‐Unity partnership explored current educational activities for EBM practice doctors across Europe. Methods We surveyed organizations offering postgraduate courses Europe inquiring their course programme, teaching content and strategies, interest in...

10.1111/j.1365-2753.2009.01268.x article EN Journal of Evaluation in Clinical Practice 2009-12-01

All commercially available triamcinolone acetonide (TACA) suspensions, used for intravitreal treatment, contain retinal toxic vehicles (e.g., benzyl alcohol, solubilizer). Our aim was to find a convenient and reproducible method compound completely preservative-free TACA suspension, adapted the intraocular physiology, with consistent quality (i.e., proven sterility stability, constant content dose uniformity, defined particle size, 1 year shelf life).We evaluated two published...

10.1089/jop.2007.0043 article EN Journal of Ocular Pharmacology and Therapeutics 2008-01-17

Abstract Purpose To prospectively assess and compare two formulations methods of administration low‐dose nasal midazolam for the treatment claustrophobic patients undergoing magnetic resonance imaging (MRI) as part a multicenter Phase III trial. Materials Methods In all, 108 consecutive adult were randomly assigned to one groups (multidose group: MDG, unit‐dose UDG). MDG encompassed 55 who received intranasally 0.5% formulation into each nostril (total dose, 1.0 mg), whereas 53 in UDG 1%...

10.1002/jmri.21552 article EN Journal of Magnetic Resonance Imaging 2008-09-26

The call by the Institute for Quality and Efficiency in Health Care (IQWiG) randomised controlled trials (RCTs) to prove patient-relevant benefit of positron emission tomography (PET) is currently a controversial topic Germany. From methodological point view there essentially no difference between diagnostic procedures therapeutic (drug or non-drug) interventions proving their causal benefit. A broad consensus has been reached since 1960s (e.g. FDA regulations) that RCTs are gold standard...

10.3413/nukmed-0320 article EN Nuklearmedizin - NuclearMedicine 2010-01-19

Steady-state pharmacokinetics of carumonam were investigated in twelve healthy adult male volunteers after 20 min intravenous infusions three consecutive dosage regimens: 1 g every 8 h (3 g/day) from 0-72 h, 2 (6 88-120 and 6 (8 132-216 h. Serial plasma samples collected the first dose regimen last all regimens analysed for by a specific HPLC method. The overall mean maximal concentrations 108 211 mg/l at end infusion g, respectively. steady-state pharmacokinetic parameters...

10.1093/jac/23.1.107 article EN Journal of Antimicrobial Chemotherapy 1989-01-01

Introduction: About 6–10% of all occurring adverse drug reactions result from drug-drug interactions [1,2]. This incidence increases in the presence risk factors, such as age or genetic constitution. Many harmful are preventable, and TDM is an effective tool that. Case reports: The following two cases illustrate need for TDM. 1) A 68 years old schizophrenic patient suffered a paralytic ileus due to clozapine intoxication (clozapine 1732ng/ml, recommended: 350–600ng/ml) after installing...

10.1055/s-0032-1326768 article EN Pharmacopsychiatry 2012-09-14
Coming Soon ...